Skip to main content
SpringerLink
Log in

Paraneoplastic Autoimmune Reactions

  • Chapter
Autoimmune Reactions

Part of the book series: Contemporary Immunology ((CONTIM))

Abstract

The purpose of this chapter is to describe inflammatory and autoimmune reactions that are secondary to the development of cancer. In some cases, it is believed that inflammatory and autoimmune reactions result from interactions between substances and cells of the immune responses that are directed against tumor cells but cross react with normal tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cobo, F., Pereira, A., Nomdedeu, B., Gallart, T., Ordi, J., Tome, A., et al. (1996) Ovarian dermoid cyst-associated autoimmune hemolytic anemia: A case report with emphasis on pathogenic mechanisms. J. Clin. Pathol. 105, 567–571.

    CAS  Google Scholar 

  2. Plotz, P. H. (1983) Autoantibodies are anti-idiotype antibodies to anti-viral antibodies. Lancet 2, 824–829.

    PubMed  CAS  Google Scholar 

  3. Van Roenn, J., Harris, J.E., and Braun, D. P. (1987) Suppressor cell function in solid tumor cancer patients. J. Clin. Oncol. 5, 150–159.

    Google Scholar 

  4. Saikia, N. K. (1972) Extraction of pemphigus antibodies from a lymphoid neoplasm and its possible relationship to pemphigus vulgaris. Br. J. Dermatol. 86, 411–414.

    PubMed  CAS  Google Scholar 

  5. Bataille, R., Klein, B., Dune, B. G. M., and Sany, J. (1989) Interrelationship between autoimmunity and B-lymphoid cell oncogenesis in humans. Clin. Exp. Rheumatol. 7, 319–328.

    PubMed  CAS  Google Scholar 

  6. Lang, B. and Vincent, A. (1996) Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. Curr. Opin. Immunol. 8, 865–871.

    PubMed  CAS  Google Scholar 

  7. Darnell, R. B. (1996) Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer, immunity, and the brain. Proc. Natl. Acad. Sci. USA 93, 4529–4536.

    PubMed  CAS  Google Scholar 

  8. Anderson, N. E., Rosenblum, M. K., Graus, F., Wiley, R. G., and Posner, J. B. (1988) Auto-antibodies in paraneoplastic syndromes in small cell lung cancer. Neurology 38, 1391–1398.

    PubMed  CAS  Google Scholar 

  9. Furneaus, H. F., Reich, L., and Posner, J. B. (1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40, 1085–1091.

    Google Scholar 

  10. Liu, J., Dalmau, J., Szabo, A., Rosenfeld, M., Huber, J., and Furneaux, H. (1995) Paraneoplastic encephalomyelitis antigens bind to the AU-rich elements of mRNA. Neurology 45, 544–550.

    PubMed  CAS  Google Scholar 

  11. Richardson, G. E. and Johnson, B. E. (1992) Paraneoplastic syndromes in lung cancer. Curr. Opin. Oncol. 4, 323–333.

    PubMed  CAS  Google Scholar 

  12. Henson, R. A. and Urich, H. (1982) Cortical cerebellar degeneration, in Cancer and the Nervous System (Henson, R. A. and Urich, H., eds.), Blackwell Scientific, London, pp. 346–367.

    Google Scholar 

  13. Cunningham, J., Graus, F., Anderson, N., and Posner, J. B. (1986) Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 36, 1163–1168.

    PubMed  CAS  Google Scholar 

  14. Anderson, N. E., Rosenblum, M. K., and Posner, J. B. (1988) Paraneoplastic cerebellar degeneration: Clinical immunological correlations. Ann. Neurol. 24, 559–567.

    PubMed  CAS  Google Scholar 

  15. Furneaux, H. M., Rosenblum, M. K., Dalmau, J., Wong, E., Woodruff, P., Graus, F., et al. (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl. J. Med. 322, 844–1851.

    Google Scholar 

  16. Fathallah-Shaykh, H., Wolf, S., Wong, E., Posner, J. B., and Furneaux, H. M. (1991) Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc. Natl. Acad. Sci. USA 88, 3451–3454.

    PubMed  CAS  Google Scholar 

  17. Fueyo, J., Ferrer, I., Valldeoriola, F., and Graus, F. (1993) The expression of a neuronal nuclear antigen (Ri) recognized by the human anti-Ri autoantibody in the developing rat nervous system. Neurosci. Lett. 162, 141–144.

    PubMed  CAS  Google Scholar 

  18. Thirkill, C. E. (1996) Lung cancer-induced blindness. Lung Cancer 14, 253–264.

    PubMed  CAS  Google Scholar 

  19. Lafeuillade, A., Quilichini, R., Chiozza, R., Pellegrino, P., and Thirkill, C. E. (1993) Paraneoplastic retinopathy (CAR syndrome) revealing prostatic cancer. Presse Med. 22, 35.

    PubMed  CAS  Google Scholar 

  20. Thirkill, C. E. (1994) Cancer associated retinopathy, the CAR syndrome. Neuro-ophthalmol. 14, 297–323.

    Google Scholar 

  21. Dizhoor, A. M., Ray, S., Kumar, S., Niemi, G., Spencer, M., Brolley, D., et al. (1991) Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science 251, 915–918.

    PubMed  CAS  Google Scholar 

  22. Polans, A. S., Burton, M. D., Halet, T. L., Crabb, J. W., and Palczewski, K. (1993) Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest. Ophthalmol. Vis. Sci. 34, 81–90.

    PubMed  CAS  Google Scholar 

  23. Lem, J., Flannery, J. G., Li, T., Applebury, M. L., Farber, D. B., and Simon, M. I. (1992) Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit. Proc. Natl. Acad. Sci. USA 89, 4422–4426.

    PubMed  CAS  Google Scholar 

  24. Smith, D. P., Ranganathan, R., Hardey, R. W., Marx, J., Tsuchida, T., and Zuker, C. S. (1991) Photoreceptor deactivation and retinal degeneration mediated by a photoreceptor-specific protein kinase C. Science 254, 1478–1484.

    PubMed  CAS  Google Scholar 

  25. Moersch, F. P. and Woltman, H. W. (1956) Progressive fluctuating muscular rigidity and spasm (”stiff-man syndrome”): report of a case and some observations in 13 other cases. Mayo Clin. Proc. 31, 421–427

    CAS  Google Scholar 

  26. Folli, F., Solimena, M., Cofiell, R., Austoni, M., Tallini, G., Fassetta, G., et al. (1993) Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer. N. Engl. J. Med. 328, 546–551.

    PubMed  CAS  Google Scholar 

  27. Grimaldi, L. M. E., Martino, G., Braghi, S., Quattrini, A., Furlan, R., Bosi, E., et al. (1993) Heterogeneity of autoantibodies in stiff-man syndrome. Ann. Neurol. 34, 57–64.

    PubMed  CAS  Google Scholar 

  28. David, C., McPherson, P. S., Mundigl, O., and De Camilla, P. (1996) A role of amphiphysin in synaptic vesical endocytosis suggested by its binding to dynamin in nerve terminals. Proc. Natl. Acad. Sci. USA 93, 331–335.

    PubMed  CAS  Google Scholar 

  29. O’Neill, J. H., Murray, N. M., and Nesom-Davis, J. (1988) The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111, 577–596.

    Google Scholar 

  30. Viglione, M. P., O’Shaughnessy, J., and Kim, Y. I. (1995) Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J. Physiol. 488, 303–317.

    PubMed  CAS  Google Scholar 

  31. Vincent, A. (1994) Aetiological factors in development of myasthenia gravis. Adv. Neuroimmunol. 4, 355–371.

    PubMed  CAS  Google Scholar 

  32. Marx, A., Wilisch, A., Schultz, A., Greiner, A., Magi, B., Pallini, V., et al. (1996) Expression of neurofilaments and of a titin epitope in thymic epithelial tumors: implications for the pathogenesis of myasthenia gravis. Am. J. Pathol. 148, 1839–1850.

    PubMed  CAS  Google Scholar 

  33. Kaminski, H. J., Fenstermaker, R. A., Abdul-Karim, F. W., Clayman, J., and Ruff, R. L. (1993) Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 16, 1332–1337.

    PubMed  CAS  Google Scholar 

  34. Evers, J., Albert, F., Bazar, L., Sulica, V., and Sacher, R. A. (1992) Autoimmune hemolytic anemia presenting in Sezary syndrome: report of a case and review of the literature. Acta Haematol. 88, 46–49.

    PubMed  CAS  Google Scholar 

  35. Frenkel, E. P., Bick, R. L., and Rutherford, C. J. (1996) Anemia of malignancy. Hematol./Oncol. Clin. North Am. 10, 861–873.

    CAS  Google Scholar 

  36. Joly, P., Thomine, E., Gilbert, D., Verdier, S., Delpech, A., Prost, C., et al. (1994) Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J. Invest. Dermatol. 103, 65–72.

    PubMed  CAS  Google Scholar 

  37. Masayuki, A., Klaus-Kovtun, V., and Stanley, J. R. (1991) Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67, 869–877.

    Google Scholar 

  38. Anhalt, G. J., Kim, S. C., Stanley, J. R., Korman, N. J., Jabs, D. A., Kory, M., et al. (1990) Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N. Engl. J. Med. 323, 1729–1735.

    PubMed  CAS  Google Scholar 

  39. Helm, T. N., Camisa, C., Valenzuela, R., and Allen, C. M. (1993) Paraneoplastic pemphigus. A distinct autoimmune vesiculobullous disorder associated with neoplasia. Oral Surg. Oral Med. Oral Pathol. 75, 209–213.

    PubMed  CAS  Google Scholar 

  40. Camisa, C., Helm, T. N., Liu, Y. C., Valenzuela, R., Allen, C., Bona, S., et al. (1992) Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J. Am. Acad. Dermatol. 27, 547–553.

    PubMed  CAS  Google Scholar 

  41. Mastaglia, F. L. and Ojeda, V. J. (1985) Inflammatory myopathies: Part 1. Ann. Neurol. 17, 217–227.

    Google Scholar 

  42. Barnes, B. E. (1976) Dermatomyositis and malignancy. A review of the literature. Ann. Intern. Med. 84, 68–76.

    PubMed  CAS  Google Scholar 

  43. Callen, J. P. (1982) The value of malignancy evaluation in patients with dermatomyositis. J. Am. Acad. Dermatol 6, 253–259.

    PubMed  CAS  Google Scholar 

  44. Callen, J. P. (1984) Myositis and malignancy. Clin. Rheum. Dis. 10, 117–130.

    PubMed  CAS  Google Scholar 

  45. Emslie-Smith, A. M. and Engel, A. G. (1990) Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann. Neurol. 27, 343–344.

    PubMed  CAS  Google Scholar 

  46. Kissel, J. T., Mendell, J. R., and Rammohan, K. W. (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N. Engl. J. Med. 314, 331–334.

    Google Scholar 

  47. Targoff, I. N. (1993) Humoral immunity in polymyositis/dermatomyositis. J. Invest. Dermatol. 100, 116S–123S.

    PubMed  CAS  Google Scholar 

  48. Vial, T. and Descotes, J. (1995) Immune-mediated side-effects of cytokines in humans. Toxicology 105, 31–57.

    PubMed  CAS  Google Scholar 

  49. Schnatter, A. (1994) Lymphokines in autoimmunity-A critical review. Clin. Immunol. Immunopathol. 70, 177–189.

    Google Scholar 

  50. Ronnblom, L. E., Aim, G. V., and Oberg, K. E. (1991) Autoimmunity after alpha-interferon therapy for malignant carcinoid tumor. Ann. Intern. Med. 1151, 178–183.

    Google Scholar 

  51. Ronnblom, L. E., Alm, G. V., and Oberg, K. E. (1990) Possible induction of systemic lupus erythematosus by interferon-a treatment in a patient with a malignant carcinoid tumor. J. Intern. Med. 227, 207–210.

    PubMed  CAS  Google Scholar 

  52. Wolfe, J. T., Singh, A., Lessin, S. R., Jaworsky, C., and Rook, A. H. (1995) De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma. J. Am. Acad. Dermatol. 32, 887–893.

    PubMed  CAS  Google Scholar 

  53. Pangalis, G. and Griva, E. (1988) Recombinant alfa-2b interferon therapy in untreated stages A and B chronic lymphocytic leukemia. Cancer 1, 869–872.

    Google Scholar 

  54. Abdi, E. A., Brien, W., and Venner, P. M. (1986) Auto-immune thrombocytopenia related to interferon therapy. Scan. J. Haematol. 36, 515–519.

    CAS  Google Scholar 

  55. Atkins, M. B., Mier, J. W., Parkinson, D. R., Gould, J. A., Berkman, E. M., and Kaplan, M. M. (1988) Hypothyroidism after treatment with interleukin-2 and lym-phokine-activated killer cells. N. Engl. J. Med. 318, 1557–1563.

    PubMed  CAS  Google Scholar 

  56. Perez, R., Padavic, K., Krigel, R., and Weiner, L. (1991) Antierythrocyte auto-antibody formation after therapy with interleukin-2 and gamma-interferon. Cancer 67, 2512–2517.

    PubMed  CAS  Google Scholar 

  57. Soni, N., Meropol, N. J., Porter, M., and Caligiur, M. A. (1996) Diabetes mellitus induced by low-dose interleukin-2. Cancer Immunol. Immunother. 43, 59–62.

    PubMed  CAS  Google Scholar 

  58. Massorotti, E. M., Canaso, J., Mier, J. W., and Atkins, M. B. (1992) Chronic inflammatory arthritis following treatment with high dose interleukin-2 for malignancy. Am. J. Med. 92, 693–697.

    Google Scholar 

  59. Engelhardt, M., Rump, J. A., Hellerich, U., Mertelsmann, R., and Lindemann, A. (1995) Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low dose interleukin-2. Annu. Hematol. 70, 227–230.

    CAS  Google Scholar 

  60. Hess, A. D., Jones, R. J., Morris, L. E., Noga, S. J., Vogelsang, G. B., and Santos, G. W. (1992) Autologous graft-versus-host disease: a novel approach for antitu-mor immunotherapy. Hum. Immunol. 34, 219–224.

    PubMed  CAS  Google Scholar 

  61. Weiden, P. L., Flournoy, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D., et al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 100, 1068–1073.

    Google Scholar 

  62. Ringden, O., Rozman, C., Speck, B., Truitt, R. I., Zwaan, F. E., and Bortin, M. M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555–562.

    PubMed  Google Scholar 

  63. Martin, P. and Kernan, N. (1990) T cell depletion for the prevention of graft-versus-host disease, in Graft-versus-Host Disease (Burakoff, S. J., Deeg, N. J., Ferrara, J., and Atkinson, K., eds.), Marcel Dekker, New York, p. 371.

    Google Scholar 

  64. Kennedy, M. J., Vogelsang, G. B., Jones, R. J., Farmer, E. R., Hess, A. D., Altomonte, V., et al. (1994) Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J. Clin. Oncol. 12, 249–257.

    PubMed  Google Scholar 

  65. Jones, R. J., Vogelsang, G. B., Hess, A. D., Farmer, E. R., Mann, R. B., Geller, R. B., et al. (1989) Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1, 754–757.

    PubMed  CAS  Google Scholar 

  66. Abdel-Wahab, Z., Dar, M. M., Hester, D., Vervaert, C., Gangavalli, R., Barber, J., et al. (1996) Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells. Cellular Immunol. 171, 246–254.

    CAS  Google Scholar 

  67. Mullen, C. A., Petropoulos, D., and Lowe, R. M. (1996) Treatment of microscopic pulmonary mestases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes. Cancer Research 56, 1361–1366.

    PubMed  CAS  Google Scholar 

  68. Levitsky, H. I., Montgomery, J., Ahmadzadeh, M., Staveley-O’Carroll, K., Guarnieri, F., Longo, D. L., et al. (1996) Immunization with granulocyte-macro-phage colony stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J. Immunol. 156, 3858–3865.

    PubMed  CAS  Google Scholar 

  69. Zatloukal, K., Schmidt, W., Cotten, M., Wagner, E., Stingi, G., and Birnstiel, M. L. (1993) Somatic gene therapy for cancer: the utility of transferrinfection in generating ‘tumor vaccines’. Gene 135, 199–207.

    PubMed  CAS  Google Scholar 

  70. Fujii, H., Inobe, M., Kimura, F., Murata, J., Murakami, M., Onishi, Y., et al. (1996) Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int. J. Cancer. 66, 219–224.

    PubMed  CAS  Google Scholar 

  71. Herlyn, D., Somasundaram, R., Li, W., and Jacob, L. (1995) Animal models of human derived cancer vaccines. Cell Biophys. 27, 15–30.

    PubMed  CAS  Google Scholar 

  72. Williams, S. S., Alosco, T. R., Croy, B. A., and Bankert, R. B. (1993) The study of human neoplastic disease in severe combined immunodeficient mice. Lab. Animal Science 43, 139–146.

    CAS  Google Scholar 

  73. Ciernik, I. F., Berzofsky, J. A., and Carbone, D. P. (1996) Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156, 2369–2375.

    PubMed  CAS  Google Scholar 

  74. Mayordomo, J. I., Loftus, D. J., Sakamoto, H., De Cesare, C. M., Appasamy, P. M., Lotze, M. T., et al. (1996) Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. J. Exp. Med. 183, 1357–1365.

    PubMed  CAS  Google Scholar 

  75. Renner, C., Jung, W., Sahin, U., Denfeld, R., Pohl, C., Trümper, L., et al. (1994) Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells. Science 264, 833–835.

    PubMed  CAS  Google Scholar 

  76. Qi, Y., Moyana, T., Matte, G., Wilkinson, A., Bresalier, R., and Xiang, J. (1995) Immunolocalization of hepatic metastases of human colonic cancer by chimeric anti-TAG72 antibody in SCID mice. J. Surg. Oncol. 59, 3–9.

    PubMed  CAS  Google Scholar 

  77. Rowse, G., Tempero, R., VanLith, M., Hollingsworth, M. A., and Gendler, S. (1998) Immunological tolerance and tumor immunity in MUC1 transgenic mice. Cancer Res. 58, 315–321.

    PubMed  CAS  Google Scholar 

  78. Hu, J., Kindsvogel, W., Busby, S., Bailey, M. C., Shi, Y., and Greenberg, P. D. (1993) An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues. J. Exp. Med. 177, 1681–1690.

    PubMed  CAS  Google Scholar 

  79. Naftzger, C., Takechi, Y., Kohda, H., Hara, I, Vijayasaradhi, S., and Houghton, A. N. (1996) Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity. Proc. Natl. Acad. Sci. USA 93, 14,809–814,814.

    Google Scholar 

  80. Hara, I., Takechi, Y., and Houghton, A. N. (1995) Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. 182, 1609–1614.

    PubMed  CAS  Google Scholar 

  81. Uyttenhove, C., Godfraind, C., Lethe’, B., Amar-Costesec, A., Renauld, J-C., Gajewski, T. F., et al. (1997) The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int. J. Cancer. 70, 349–356.

    PubMed  CAS  Google Scholar 

  82. Dahl, A. M., Beverley, P. C. L., and Stauss, H. J. (1996) A synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognize naturally processed protein. J. Immunol. 157, 239–246.

    PubMed  CAS  Google Scholar 

  83. Disis, M. L., Gralow, J. R., Bernhard, H., Hand, S. L., Rubin, W. D., and Cheever, M. A. (1996) Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, an oncogenic self-protein. J. Immunol. 156, 3151–3158.

    PubMed  CAS  Google Scholar 

  84. Bevan, M. J., Hogquist, K. A., and Jameson, S. C. (1994) Selecting the T cell receptor repertoire. Science 264, 796–797.

    PubMed  CAS  Google Scholar 

  85. von Boehmer, H. (1994) Positive selection of lymphocytes. Cell 76, 219–228.

    Google Scholar 

  86. Anderson, G., Moore, N. C., Owen, J. J. T., and Jenkinson, E. J. (1996) Cellular interactions in thymocyte development. Annu. Rev. Immunol. 14, 73–100.

    PubMed  CAS  Google Scholar 

  87. Mamula, M. J. and Craft, J. (1994) The expression of self antigenic determinants: implications for tolerance and autoimmunty. Curr. Opion. Immunol. 6, 882–886.

    CAS  Google Scholar 

  88. Mamula, M. J. (1993) The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177, 567–571.

    PubMed  CAS  Google Scholar 

  89. Moudgil, K. D. and Sercarz, E. E. (1994) The T cell reportiore against cryptic self determinants and its involvement in autoimmunity and cancer. Clinical Immunol. Immunpathol. 73, 283–289.

    CAS  Google Scholar 

  90. Vanderlugt, C. J. and Miller, S. D. (1996) Epitope spreading. Curr. Opin. Immunol. 8, 831–836.

    PubMed  CAS  Google Scholar 

  91. McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C., and Miller, S. D. (1995) Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med. 182, 75–85.

    PubMed  CAS  Google Scholar 

  92. James, J. A., Gross, T., Scofield, R. H., and Harley, J. B. (1995) Immunoglobulin epitopes spreading and autoimmune disease after peptide immunization: Sm B/B’-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181, 453–461.

    PubMed  CAS  Google Scholar 

  93. Lou, Y. and Tung, K. S. K. (1993) T cell peptide of a self-protein elicits autoanti-body to the protein antigen. J. Immunol. 151, 5790–5799.

    PubMed  CAS  Google Scholar 

  94. Kawakami, Y., Eliyaha, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., et al. (1995) Recognition of multiple epitopes in a human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J. Immunol. 154, 3961–3968.

    PubMed  CAS  Google Scholar 

  95. Mondino, A., Khoruts, A., and Jenkins, M. K. (1996) The anatomy of T-cell activation and tolerance. Proc. Natl. Acad. Sci. USA 93, 2245–2252.

    PubMed  CAS  Google Scholar 

  96. Goodnow, C. C. (1996) Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93, 2264–2271.

    PubMed  CAS  Google Scholar 

  97. Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258.

    PubMed  CAS  Google Scholar 

  98. Pardoll, D. (1993) New strategies for enhancing the immunogenicity of tumors. Curr. Opin. Immunol. 5, 719–725.

    PubMed  CAS  Google Scholar 

  99. Ramarathinam, L., Castle, M., Wu, Y., and Liu, Y. (1994) T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/ BB1 in the induction, recruitment, and effector function of antitumor cells. J. Exp. Med. 179, 1205–1214.

    PubMed  CAS  Google Scholar 

  100. Miller, J. F. and Flavell, R. A. (1994) T-cell tolerance and autoimmunity in trans-genic models of central and peripheral tolerance. Curr. Opin. Immunol. 6, 892–899.

    PubMed  CAS  Google Scholar 

  101. Guerder, S., Meyerhoff, J., and Flavell, R. (1994) The role of the T cell costim-ulator B7-1 in autoimmuntiy and the induction and maintenance of tolerance to peripheral antigen. Immunity 1, 155–166.

    PubMed  CAS  Google Scholar 

  102. Klinman, N. R. (1996) The ‘clonal selection hypothesis’ and current concepts of B cell tolerance. Immunity 5, 189–195.

    PubMed  CAS  Google Scholar 

  103. Erikson, J., Radic, M. Z., Camper, S. A. Hardy, R. R., Carmack, C., and Weigert, M. (1991) Expression of anti-DNA immunoglubulin transgenes in non-autoimmune mice. Nature 349, 331–334.

    PubMed  CAS  Google Scholar 

  104. Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie T. B., Smithgill, S. J., Brink, R. A., et al. (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes. Nature 334, 676–679.

    PubMed  CAS  Google Scholar 

  105. Russell, D. M., Dembic, Z., Morahan, G., Miller, J. F. A. P., Burki, K., and Nemazee, D. Peripheral deletion of self-reactive B cells. Nature 354, 308–311.

    Google Scholar 

  106. Nemazee, D. A. and Burki, K. (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337, 562–566.

    PubMed  CAS  Google Scholar 

  107. Okamoto, M. Murakami, M., Shimizu, A., Ozaki, S., Tsubata, T., Kumagai, S., et al. (1992) A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175, 71–79.

    PubMed  CAS  Google Scholar 

  108. Schlichtholz, B., Legros, Y., Gillet, C., Marty, M., Lane, D., Calve, F., et al. (1992) The immune response to p53 in breast cancer patients is directed against immuno-dominant epitopes unrelated to the mutational hot spot. Cancer Res. 52, 6380–6384.

    PubMed  CAS  Google Scholar 

  109. Disis, M. and Cheever, M. A. (1996) Oncogenic proteins as tumor antigens. Curr. Opin. Immunol. 8, 637–642.

    PubMed  CAS  Google Scholar 

  110. Katsumata, M., Okudaira, T., Samanta, A., Clark, D. P., Drebin, J. A., Jolicoeur, P., et al. (1995) Prevention of breast tumor development in vivo by downregulation of the p815neu receptor}. Nat. Med. 1, 644–648.

    PubMed  CAS  Google Scholar 

  111. Townsend, S. E. and Allison, J. P. (1993) Tumor rejection after direct costim-ulation of CD8+ T cells by B7-transfected melanoma cells. Science 259, 368–370.

    PubMed  CAS  Google Scholar 

  112. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., et al. (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093–1102.

    PubMed  CAS  Google Scholar 

  113. Chen, L., McGowen, P., Ashe, S., Johnston, J., Li, Y., Hellstrom, I., and Hellstrom, K. E. (1994) Tumor immunogenicity determines the effect of B7 costimulation of T cell-mediated tumor immunity. J. Exp. Med. 179, 523–532.

    PubMed  CAS  Google Scholar 

  114. Basker, S., Ostrand-Rosenburg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., and Glimcher L. H. (1993) Constitutive expression of B7 restores immunogencity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 90, 5687–5690.

    Google Scholar 

  115. Fujii, H., Inobe, M., Kimura, F., Murata, J., Murakami, M., Onishi, Y., et al. (1996) Vaccination of tumor cells transfected with B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int. J. Cancer 66, 219–224.

    PubMed  CAS  Google Scholar 

  116. Yang, G., Hellstrom, K. E., Hellstrom, I., and Chen L. (1995) Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154, 2794–2800.

    PubMed  CAS  Google Scholar 

  117. Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, M., Gatti, E., Tornaghi, P., et al. (1995) Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25, 1154–1162.

    PubMed  CAS  Google Scholar 

  118. Rivera, J. A., Rall, C. J., Graeme-Cook, F., Fernandez-del-Castillo, C., Shu, P., Lakey, N., et al. (1997) Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia. Surgery 121, 42–49.

    PubMed  CAS  Google Scholar 

  119. Uehara, H., Nakaizumi, A., Baba, M., Iishi, H., Tatsuta, M., Kitamura, T., et al. (1996) Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice. Am. J. Gastroenterol. 91, 1616–1621.

    PubMed  CAS  Google Scholar 

  120. Raedle, J., Oremek, G., Welker, M., Roth, W. K., Caspary, W. F., and Zeuzem, S. (1996) p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma. Pancreas 13, 241–246.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Connie L. Sivinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard M. Tempero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michelle L. VanLith
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Hollingsworth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Health Sciences Center, University of Texas Medical School, Houston, TX, USA

    Sudhir Paul

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sivinski, C.L., Tempero, R.M., VanLith, M.L., Hollingsworth, M.A. (1999). Paraneoplastic Autoimmune Reactions. In: Paul, S. (eds) Autoimmune Reactions. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1610-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1610-0_22

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-7215-1

  • Online ISBN: 978-1-4612-1610-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation